• News
  • Canadian researchers will test a promising new fecal microbiota treatment on patients to cure advanced melanoma

Canadian researchers will test a promising new fecal microbiota treatment on patients to cure advanced melanoma

May 15, 2024

Today marks an exciting advancement in the fight against cancer as the Weston Family Foundation, in tandem with the Canadian Cancer Society and Canadian Cancer Trials Group proudly announce funding into pioneering microbiome research aimed at enhancing cancer treatment strategies. This groundbreaking investment signifies a bold leap forward in understanding the intricate interplay between the human microbiome and cancer progression. 

It is estimated that 11,300 Canadians will be diagnosed with melanoma in 2024, underscoring the urgent need for novel therapeutic avenues. The Weston Family Foundation through its Microbiome Initiative has been investing in microbiome research for the past five years. The Foundation believes that harnessing the power of the microbiome could hold immense promise in reshaping the landscape of cancer care. This transformative funding initiative emphasizes our unwavering commitment to investing in innovation and learning to deliver measurable impacts to the well-being of Canadians.  

Learn more from the press release here.